CJC-1295 With DAC 5mg
Product Name: CJC-1295 With DAC Strength: 5mg Alternative Names: CJC-1295 DAC, CJC-1295 With Drug Affinity Complex Research Category: Growth Hormone-Releasing Hormone (GHRH) Analog / Endocrine Research Peptide CAS Number: 863288-34-0 Peptide Type: Synthetic GHRH Analog With Drug Affinity Complex (DAC) Research Target: Growth Hormone-Releasing Hormone Receptor (GHRHR) Research Interest: Growth hormone signaling, IGF-1 regulation, pituitary function, GHRH receptor activity, endocrine physiology, and prolonged peptide pharmacology. Description
CJC-1295 With DAC is a synthetic growth hormone-releasing hormone (GHRH) analog developed for research into growth hormone and IGF-1 signaling. The molecule incorporates a Drug Affinity Complex (DAC), designed to bind covalently to circulating albumin and thereby extend its persistence compared with shorter-acting GHRH analogs. Mechanism of Research
CJC-1295 acts through growth hormone-releasing hormone receptors on pituitary somatotroph cells. Activation of these receptors stimulates signaling associated with endogenous growth hormone release and downstream IGF-1 activity. The DAC modification is designed to increase albumin binding and prolong exposure to the peptide. Research Applications
Research involving CJC-1295 With DAC includes GHRH receptor signaling, growth hormone secretion, GH/IGF-1 axis regulation, pituitary physiology, endocrine signaling, and investigation of extended-duration GHRH analogs. Storage
Storage requirements depend on the formulation and supplier. Research material should be stored according to the accompanying certificate of analysis (COA), product specification sheet, and manufacturer instructions. Research Use Disclaimer
CJC-1295 With DAC is an investigational research peptide and is not an approved therapeutic product. Information provided here is for scientific and research reference purposes only and should not be interpreted as medical, prescribing, or dosing advice. 
